Soluble and cellular markers of immune activation in patients with systemic sclerosis
- 1 August 1990
- journal article
- research article
- Published by Elsevier in Clinical Immunology and Immunopathology
- Vol. 56 (2) , 259-270
- https://doi.org/10.1016/0090-1229(90)90147-i
Abstract
No abstract availableThis publication has 23 references indexed in Scilit:
- A retrospective study of antibodies against basement membrane antigens (type iv collagen and laminin) in patients with primary and secondary raynaud's phenomenonArthritis & Rheumatism, 1988
- Increased helper inducer and decreased suppressor inducer phenotypes in the rheumatoid jointArthritis & Rheumatism, 1988
- Deficiency of the suppressor inducer subset of T lymphocytes in rheumatoid arthritisArthritis & Rheumatism, 1987
- Abnormal lymphocyte function in scleroderma: A study on identical twinsClinical Immunology and Immunopathology, 1987
- A defect of immunoregulatory T cell subsets in systemic lupus erythematosus patients demonstrated with anti-2H4 antibody.Journal of Clinical Investigation, 1987
- Selective Loss of the Suppressor-Inducer T-Cell Subset in Progressive Multiple SclerosisNew England Journal of Medicine, 1987
- Differences in the production of and/or the response to interleukin-2 by T lymphocytes from patients with the various connective tissue diseasesRheumatology International, 1984
- T-cell subpopulations in the peripheral blood of patients with connective tissue diseases as determinated by flow cytometry using monoclonal antibodiesClinical Immunology and Immunopathology, 1983
- T cell growth factor receptors. Quantitation, specificity, and biological relevanceThe Journal of Experimental Medicine, 1981
- Properties of a basement membrane-related glycoprotein synthesized in culture by a mouse embryonal carcinoma-derived cell lineCell, 1979